Autism Spectrum Disorders (ASD) – Searching for the Biological Basis for Behavioral Symptoms and New Therapeutic Targets

In previous publications, Cell-El discussed:

  • Immune dysfunction in ASD
  • Stem cells as a possible treatment directed at this biomedical issue
  • Biomarkers as a basis for ASD diagnostics and guiding of treatment.

In this post, we present to you:

Cell El’s team was honored with editing a special edition of the Frontiers Journal Research Topic 2017 Edition of: Autism Spectrum Disorders (ASD) – Searching for the Biological Basis for Behavioral Symptoms and New Therapeutic Targets

Editors: Benjamin Gesundheit, Joshua Rosenzweig and Yehuda Shoenfeld

This is an open-access book which compiles evidence of the biological basis of Autism Spectrum Disorders which are setting the stage for understanding the mechanisms underlying the behavioral symptoms of the condition and for development of targeted therapeutics. 

In the Opening Editorial Cell El’s Researchers Write:

“The frequency of Autism Spectrum Disorders (ASD) is increasing with a 30% reported increase in pediatric prevalence from 2012 to 2014 in the U.S. until present rates of about 1 in 68 children or 1.5% of children in the U.S. (Corcoran et al., 2015). Yet, little is known about the etiology of this spectrum. As of now, ASD is diagnosed based on a series of behavioral tests. The challenge for researchers is to try to uncover the biological basis for these typical behaviors in order to improve diagnosis and identify potential targets for treatment. A multidisciplinary approach to understanding the biological basis for the behavioral symptoms is necessary in order to move forward. This includes analysis of the current animal models for ASD and their suitability, reviewing behavioral, immunological, immunogenetic, and epigenetic research, reassessing clinical diagnostic tools, and surveying radiological, pathological, and serological records for clues. With over 500 animal models available with varying construct validity and face validity, and a variety of behavioral tests for animals (Kazdoba et al., 2016; three chamber, T maze, elevated plus maze) and for humans (ADOS, ADIR, CARS, ABC) and still no FDA approved effective treatments for the core symptoms of autism, much more needs to be done to understand the behavioral features of autism and their underlying etiology.”

This journal collection of 13 scholarly articles taken from Frontiers in Neuroscience and Frontiers in Pediatrics attempts to give the reader an overview of the latest works in the field. 

“Though there is still much work to do in uncovering the biological basis for ASD, patterns are beginning to emerge. The combination of serological data with genetic data enables researchers to isolate pathways that demonstrate particular association with ASD. The precise mechanisms between these networks and the behavioral symptoms have yet to be fully elucidated. However, larger studies with more unified diagnostic inclusion criteria and multidisciplinary testing will hopefully yield further hints toward identifying the underlying mechanism of ASD.”

To access this online book and learn more about the biological basis of ASD – please click here

To help further our research on the understanding of the biological basis of ASD- please join our study!

Help Us Help You

Better diagnostics for ASD based on laboratory-measured objective biomarkers can possibly enable researchers and clinicians to provide more precise and personalized treatment. You too can make a difference in the lives of children with ASD and their families by joining the Cell-El study. Cell-El is recruiting for two of our study cohorts. We are recruiting mothers, and their infants aged 10-19 months who have not been diagnosed with ASD but who have a sibling diagnosed with ASD. Cell-El is also recruiting children diagnosed with ASD between the ages of 2-18 years old whose parents are planning to take them privately to a clinic offering Stem Cell treatment for ASD. 

Please contact Leah at [email protected] or fill out the form to find out about eligibility to participate in  our diagnostic study and please help spread the word about the Cell-El study. Sharing our study will enable our important biomarker diagnostic tool to be integrated into autism treatment as quickly as possible.